Search -

Displaying 41 - 60 of 64

Sort: Relevancy | Date

Presentation Stanford Coronary Physiology Conference 2016

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

Presenter: Nils P. Johnson

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in... Bifucation Disease

Presenter: Nils P. Johnson

October 28, 2016

Presentation TCT 2015

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Presenter: Allen Jeremias, Nils Johnson, Habib Samady

October 12, 2015

Presentation TCT 2015

Left Main Disease: When to Use FFR vs IVUS

Presenter: Allen Jeremias, Nils Johnson, William F. Fearon

October 12, 2015

Presentation TCT 2015

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Presenter: Allen Jeremias, Nils Johnson, Colin Berry

October 12, 2015

Presentation TCT 2015

Fifteen-Year DEFER and 5-Year FAME Outcomes

Presenter: Allen Jeremias, Nils Johnson, Nico H.J. Pijls

October 12, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

News Daily News

元分析证实了FFR引导血运重建的益处

Yael L. Maxwell

October 24, 2014

News Daily News

Un Meta Análisis Confirma los Beneficios de la Revascularización guiada mediante FFR

Yael L. Maxwell

October 24, 2014

News Daily News

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Yael L. Maxwell

October 24, 2014

Presentation

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Presenter: Nils P. Johnson

October 16, 2014

Presentation TCT 2014

Role of Intravascular Imaging in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Colin Berry

September 16, 2014

Presentation Physiology and Intravascular Imaging 2014

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Presenter: Nils P. Johnson

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Case Studies: FFR Artifacts

Presenter: Nils P. Johnson

March 27, 2014

Presentation TCT 2013

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

Presenter: Nils Johnson

October 30, 2013

Presentation TCT 2013

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Presenter: Nils P. Johnson

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Advertisement

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

FFR in... Bifucation Disease

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Left Main Disease: When to Use FFR vs IVUS

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Fifteen-Year DEFER and 5-Year FAME Outcomes

The Ischemic Continuum: What Is the Significance of a Lower FFR?

元分析证实了FFR引导血运重建的益处

Un Meta Análisis Confirma los Beneficios de la Revascularización guiada mediante FFR

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Role of Intravascular Imaging in NSTE-ACS and STEMI

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Case Studies: FFR Artifacts

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content